Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pernix Theraptcs (PTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Pernix Therapeutics Announces Participation in Lead Bid for Acquisition of Worldwide Rights to Contrave(R) for Weight Loss

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that it has agreed to participate in an investor group (collectively with Pernix, the "Investors") that...

OREX : 0.22 (-34.41%)
PTX : 2.36 (-0.84%)
Wired News - Amarin's REDUCE-IT Study Reached 100% Mark for Estimated Onset of Targeted Primary MACE

Stock Monitor: Pernix Therapeutics Holdings Post Earnings Reporting

PTX : 2.36 (-0.84%)
AMRN : 2.82 (-4.08%)
Pernix Therapeutics Announces Return to Market of Zohydro(R) ER with BeadTek(R) 20 mg

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that it expects to resume distribution of the 20 mg dosage strength of Zohydro(R) ER (hydrocodone bitartrate)...

PTX : 2.36 (-0.84%)
Pernix Therapeutics Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 8, 2018 / Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX) will be discussing their earnings results in their Q4 Earnings Call to be held on March 8, 2018 at 4:30 PM Eastern...

PTX : 2.36 (-0.84%)
Pernix Therapeutics to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 8

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that the Company will report financial results for the fourth quarter and fiscal year ended December...

PTX : 2.36 (-0.84%)
Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced the appointment of Director John R. Leone as its Lead Independent Director. Mr. Leone joined the Pernix...

PTX : 2.36 (-0.84%)
Pernix Announces Reorganization of Sales Force to Focus on Zohydro(R) ER with BeadTek(TM) and Silenor(R)

Anticipated Cost Savings of $7-$8 Million

PTX : 2.36 (-0.84%)
Achaogen's NDA for Plazomicin Gets Priority Review From FDA

Achaogen's (AKAO) NDA for its urinary tract infections candidate, plazomicin, gets FDA's priority review.

CORT : 17.42 (-0.97%)
PTX : 2.36 (-0.84%)
AKAO : 13.07 (-2.35%)
PFE : 36.80 (+0.46%)
Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced the election of two new directors to its Board, John R. Leone and Douglas...

WINT : 3.2500 (+6.56%)
PTX : 2.36 (-0.84%)
Pernix Therapeutics Reports Third Quarter 2017 Financial Results

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, announced today financial results for the third quarter ended September 30, 2017.

PTX : 2.36 (-0.84%)
Pernix Therapeutics Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 4:30...

PTX : 2.36 (-0.84%)
Pernix Therapeutics Announces Sale of Non-Core Product

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced the sale of a non-core product, Cedax(R) (ceftibuten capsules and ceftibuten...

PTX : 2.36 (-0.84%)
Pernix Therapeutics to Report Third Quarter 2017 Financial Results on Tuesday, November 7

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, announced today that the Company will report financial results for the third quarter ended...

PTX : 2.36 (-0.84%)
Pernix Therapeutics Announces Planned Departure of Chief Financial Officer

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced that Graham Miao, Ph.D., President and Chief Financial Officer (CFO), will...

PTX : 2.36 (-0.84%)
BUYINS.NET: PTX SqueezeTrigger Price is $2.83. There is $5,107,955 That Short Sellers Still Need To Cover.

BUYINS.NET / www.buyins.net is monitoring Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) in real time and just received an alert that PTX is crossing above its primary SqueezeTrigger Price, the price that...

PTX : 2.36 (-0.84%)
Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today announced financial results for the three and six months ended June 30, 2017.

PTX : 2.36 (-0.84%)
Investor Network: Pernix Therapeutics Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX) will be discussing their earnings results in their Q2 Earnings Call to be held July 27, 2017 at 4:30 PM Eastern...

PTX : 2.36 (-0.84%)
Platinex Joins Forces With FMI Capital Advisory Inc. to Pursue Transactions in the Cannabis Space

TORONTO, ONTARIO--(Marketwired - July 25, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) ("Platinex" or the "Company") has engaged FMI Capital Advisory Inc. ("FMI") as financial advisor to assist...

PTX : 2.36 (-0.84%)
PTX.CN : 0.095 (-24.00%)
PANXF : 0.1134 (-5.34%)
Platinex Announces Expiry of Letter of Intent

TORONTO, ONTARIO--(Marketwired - July 21, 2017) - Platinex Inc. (CSE:PTX)(CSE:PTX.CN)(CNSX:PTX) (the "Company" or "Platinex") announces that the forty five day period set out in a Letter of Intent with...

PTX : 2.36 (-0.84%)
PTX.CN : 0.095 (-24.00%)
PANXF : 0.1134 (-5.34%)
Pernix Commences Refinancing Transactions to Fortify Balance Sheet

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or the "Company"), a specialty pharmaceutical company, today commenced a series of refinancing transactions intended to improve liquidity, extend...

PTX : 2.36 (-0.84%)

Van Meerten Stock Picks

5 Great Mid Caps
This morning I wanted to find the Mid Cap stocks that not only had some of the best returns in the past 12 months but still seemed to have some upside potential.
IBKR +0.16 , HFC +0.82 , ABMD -3.27 , CAR +0.43 , URBN +0.48
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures closed the Monday session with most contracts 1 to 2 cents higher. This morning’s USDA Export Inspections report indicated corn exports at 1.719 MMT for the week of 4/19. That was a jump of 9% from the previous week and 17.18% larg...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar